(16 June 2020, updated 2 April 2021) Research recently published in the Journal of Allergy and Clinical Immunology identified an increased risk of developing severe COVID-19 among those in a UK Biobank cohort with non-allergic asthma. While the study also found increased risk of developing severe COVID-19 among those with asthma and COPD, risk was not found to increase among those with allergic asthma (Zhu et al 2020 Journal of Allergy and Clinical Immunology). Also see (Zhu et al 2020 Metabolism).
Read more about the paper in the recent HSPH press release.
